Literature DB >> 10093913

Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation.

K Maeda1, M Naganuma.   

Abstract

We have studied the effect of a plasmin inhibitor, trans-4-aminomethylcyclohexanecarboxylic acid (trans-AMCHA), on skin pigmentation induced by ultraviolet (UV) exposure in Weiser-Maples guinea pigs. When guinea pigs are exposed to UV radiation (840 mJ cm-2), skin pigmentation is clearly observed from seven days after exposure and continued to increase to 29 days. Post-exposure applications of 2 and 3% solutions of trans-AMCHA to the exposed regions prevent or inhibit the pigmentation process. When the skin is removed and stained by the Fontana-Masson method, melanin content in the basal layer of UV-exposed epidermis is significantly reduced in the regions to which 2 and 3% trans-AMCHA solutions have been applied, compared with the vehicle control. As plasmin is known to contribute to the release of arachidonic acid (AA) and the production of prostaglandins (PGs), we have examined the effects of trans-AMCHA on AA-induced pigmentation in guinea pig skin. Topical application of trans-AMCHA causes a dose-dependent decrease in AA-induced pigmentation. These results suggest that trans-AMCHA reduces melanocyte tyrosinase activity by suppressing the production of PGs, UV-induced melanogens, through the suppression of the UV-induced increase in epidermal plasmin activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10093913     DOI: 10.1016/s1011-1344(98)00212-7

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  14 in total

1.  Design, synthesis and in vitro kinetic study of tranexamic acid prodrugs for the treatment of bleeding conditions.

Authors:  Rafik Karaman; Hiba Ghareeb; Khuloud Kamal Dajani; Laura Scrano; Hussein Hallak; Saleh Abu-Lafi; Gennaro Mecca; Sabino A Bufo
Journal:  J Comput Aided Mol Des       Date:  2013-07-24       Impact factor: 3.686

2.  Effects of trans-4-(aminomethyl) cyclohexanecarboxylic acid/potassium azeloyl diglycinate/niacinamide topical emulsion in Thai adults with melasma: a single-center, randomized, double-blind, controlled study.

Authors:  Jarupa Viyoch; Isaree Tengamnuay; Khemjira Phetdee; Punpimol Tuntijarukorn; Neti Waranuch
Journal:  Curr Ther Res Clin Exp       Date:  2010-12

3.  Tranexamic Acid Diminishes Laser-Induced Melanogenesis.

Authors:  Myoung Shin Kim; Seung Hyun Bang; Jeong-Hwan Kim; Hong-Ju Shin; Jee-Ho Choi; Sung Eun Chang
Journal:  Ann Dermatol       Date:  2015-05-29       Impact factor: 1.444

4.  Topical tranexamic acid as a promising treatment for melasma.

Authors:  Bahareh Ebrahimi; Farahnaz Fatemi Naeini
Journal:  J Res Med Sci       Date:  2014-08       Impact factor: 1.852

5.  Therapeutic Effects of Topical Tranexamic Acid in Comparison with Hydroquinone in Treatment of Women with Melasma.

Authors:  Najmolsadat Atefi; Behzad Dalvand; Mahammadreza Ghassemi; Golnaz Mehran; Amir Heydarian
Journal:  Dermatol Ther (Heidelb)       Date:  2017-07-26

6.  Activation of MITF by Argan Oil Leads to the Inhibition of the Tyrosinase and Dopachrome Tautomerase Expressions in B16 Murine Melanoma Cells.

Authors:  Myra O Villareal; Sayuri Kume; Thouria Bourhim; Fatima Zahra Bakhtaoui; Kenichi Kashiwagi; Junkyu Han; Chemseddoha Gadhi; Hiroko Isoda
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-08       Impact factor: 2.629

7.  A Randomised, Open-label, Comparative Study of Tranexamic Acid Microinjections and Tranexamic Acid with Microneedling in Patients with Melasma.

Authors:  Leelavathy Budamakuntla; Eswari Loganathan; Deepak Hurkudli Suresh; Sharavana Shanmugam; Shwetha Suryanarayan; Aparna Dongare; Lakshmi Dammaningala Venkataramiah; Namitha Prabhu
Journal:  J Cutan Aesthet Surg       Date:  2013-07

8.  Tyrosol and its analogues inhibit alpha-melanocyte-stimulating hormone induced melanogenesis.

Authors:  Kuo-Ching Wen; Chih-Shiang Chang; Yin-Chih Chien; Hsiao-Wen Wang; Wan-Chen Wu; Chin-Sheng Wu; Hsiu-Mei Chiang
Journal:  Int J Mol Sci       Date:  2013-11-28       Impact factor: 5.923

9.  Oral Tranexamic Acid with Fluocinolone-Based Triple Combination Cream Versus Fluocinolone-Based Triple Combination Cream Alone in Melasma: An Open Labeled Randomized Comparative Trial.

Authors:  Tanmay Padhi; Swetalina Pradhan
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

10.  Tranexamic Acid Inhibits Angiogenesis and Melanogenesis in Vitro by Targeting VEGF Receptors.

Authors:  Jian-Wei Zhu; Ya-Jie Ni; Xiao-Yun Tong; Xia Guo; Xiao-Ping Wu; Zhong-Fa Lu
Journal:  Int J Med Sci       Date:  2020-03-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.